2026
conference-abstract
OpenAlex
Peter Yuxin Xie, James P. Agolia, Rosyli F. Reveron-Thornton, Chuner Guo et autres
Abstract Purpose: Surgical resection remains the only curative treatment for pancreatic ductal adenocarcinoma (PDAC), yet only 15% of patients are resectable at diagnosis and up to 40% of patients present with locally advanced tumors involving vital vasculature. Even among those who undergo …
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Biren Reddy, Maria Moozhiyil Korah, James P. Agolia, Rosyli F. Reveron-Thornton et autres
Abstract Introduction: Solid pseudopapillary neoplasms (SPNs) of the pancreas are rare, low-grade tumors that typically affect young women and occasionally recur or metastasize. While the histological features and mutational profile of SPNs are well documented, their cell-of-origin and spatial organization remain incompletely …
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
James P. Agolia, Chuner Guo, Rosyli F. Reveron-Thornton, Xiaomo Li et autres
Abstract Introduction: Within the next five years, pancreatic ductal adenocarcinoma (PDAC) will become the second-highest cause of cancer death in the United States; even with surgical resection and chemotherapy, median overall survival remains less than three years. Spatial transcriptomic and proteomic analysis …
us
(code pays fourni par la source)